Co-delivery of gefitinib and hematoporphyrin by aptamer-modified fluorinated dendrimer for hypoxia alleviation and enhanced synergistic chemo-photodynamic therapy of NSCLC
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 167, 106004
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Bioreducible Fluorinated Peptide Dendrimers Capable of Circumventing Various Physiological Barriers for Highly Efficient and Safe Gene DeliveryACS Applied Materials & Interfaces, 2016
- Bioconjugated Manganese Dioxide Nanoparticles Enhance Chemotherapy Response by Priming Tumor-Associated Macrophages toward M1-like Phenotype and Attenuating Tumor HypoxiaACS Nano, 2015
- Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapyNature Communications, 2015
- Nanoobjects formed by ionic PAMAM dendrimers: hydrophilic/lipophilic modulation and encapsulation propertiesSoft Matter, 2015
- Intelligent MnO2 Nanosheets Anchored with Upconversion Nanoprobes for Concurrent pH‐/H2O2‐Responsive UCL Imaging and Oxygen‐Elevated Synergetic TherapyAdvanced Materials, 2015
- Oxygen delivery from hyperbarically loaded microtanks extends cell viability in anoxic environmentsBiomaterials, 2015
- The role of photodynamic therapy in overcoming cancer drug resistancePhotochemical & Photobiological Sciences, 2015
- A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratiosNature Communications, 2014
- New Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical TrialsJournal of Clinical Oncology, 2013
- Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imagingBiomaterials, 2009